164 related articles for article (PubMed ID: 36371936)
1. The combination of daptomycin with β-lactam antibiotics is more effective than daptomycin alone for vancomycin-resistant Enterococcus faecium bloodstream infection.
Chuang YC; Wang JT; Yang JL; Lin CY; Huang SH; Chen YC; Chang SC
J Infect Public Health; 2022 Dec; 15(12):1396-1402. PubMed ID: 36371936
[TBL] [Abstract][Full Text] [Related]
2. A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections.
Chuang YC; Chen PY; Lin CY; Chen YC; Wang JT; Chang SC
Sci Rep; 2018 Jan; 8(1):1632. PubMed ID: 29374204
[TBL] [Abstract][Full Text] [Related]
3. Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study.
Jorgensen SCJ; Zasowski EJ; Trinh TD; Lagnf AM; Bhatia S; Sabagha N; Abdul-Mutakabbir JC; Alosaimy S; Mynatt RP; Davis SL; Rybak MJ
Clin Infect Dis; 2020 Jun; 71(1):1-10. PubMed ID: 31404468
[TBL] [Abstract][Full Text] [Related]
4. Influence of daptomycin dose and fosfomycin susceptibility on outcome of vancomycin-resistant Enterococcus faecium bloodstream infections treated with daptomycin and fosfomycin combination.
Chuang YC; Tseng TC; Wang JT; Lin CY; Huang SH; Chen YC; Chang SC
J Antimicrob Chemother; 2022 Apr; 77(5):1436-1443. PubMed ID: 35141753
[TBL] [Abstract][Full Text] [Related]
5. Phage-Antibiotic Cocktail Rescues Daptomycin and Phage Susceptibility against Daptomycin-Nonsusceptible Enterococcus faecium in a Simulated Endocardial Vegetation
Kunz Coyne AJ; Stamper K; El Ghali A; Kebriaei R; Biswas B; Wilson M; Deschenes MV; Tran TT; Arias CA; Rybak MJ
Microbiol Spectr; 2023 Aug; 11(4):e0034023. PubMed ID: 37338375
[TBL] [Abstract][Full Text] [Related]
6. Clinical Outcomes of Daptomycin for Vancomycin-resistant Enterococcus Bacteremia.
Moise PA; Sakoulas G; McKinnell JA; Lamp KC; DePestel DD; Yoon MJ; Reyes K; Zervos MJ
Clin Ther; 2015 Jul; 37(7):1443-1453.e2. PubMed ID: 25982687
[TBL] [Abstract][Full Text] [Related]
7. β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models.
Smith JR; Barber KE; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2015 May; 59(5):2842-8. PubMed ID: 25753639
[TBL] [Abstract][Full Text] [Related]
8. Impact of Daptomycin Dose Exposure Alone or in Combination with β-Lactams or Rifampin against Vancomycin-Resistant Enterococci in an
Jahanbakhsh S; Singh NB; Yim J; Kebriaei R; Smith JR; Lev K; Tran TT; Rose WE; Arias CA; Rybak MJ
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094136
[No Abstract] [Full Text] [Related]
9. Vancomycin-resistant Enterococcal Bloodstream Infections in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies: Impact of Daptomycin MICs of 3 to 4 mg/L.
Chong PP; van Duin D; Bangdiwala A; Ivanova A; Miller WC; Weber DJ; Gilligan PH; Shea TC
Clin Ther; 2016 Nov; 38(11):2468-2476. PubMed ID: 27771176
[TBL] [Abstract][Full Text] [Related]
10. Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia.
Britt NS; Potter EM; Patel N; Steed ME
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264856
[TBL] [Abstract][Full Text] [Related]
11. Effect of Daptomycin Dose on the Outcome of Vancomycin-Resistant, Daptomycin-Susceptible Enterococcus faecium Bacteremia.
Chuang YC; Lin HY; Chen PY; Lin CY; Wang JT; Chen YC; Chang SC
Clin Infect Dis; 2017 Apr; 64(8):1026-1034. PubMed ID: 28329222
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin or Daptomycin Plus a β-Lactam Versus Vancomycin or Daptomycin Alone for Methicillin-Resistant
Yi YH; Wang JL; Yin WJ; Xu WH
Microb Drug Resist; 2021 Aug; 27(8):1044-1056. PubMed ID: 33728980
[No Abstract] [Full Text] [Related]
13. Mechanistic Insights Into the Differential Efficacy of Daptomycin Plus β-Lactam Combinations Against Daptomycin-Resistant Enterococcus faecium.
Kebriaei R; Stamper KC; Singh KV; Khan A; Rice SA; Dinh AQ; Tran TT; Murray BE; Arias CA; Rybak MJ
J Infect Dis; 2020 Oct; 222(9):1531-1539. PubMed ID: 32514561
[TBL] [Abstract][Full Text] [Related]
14. Impact of different antimicrobial therapies on clinical and fiscal outcomes of patients with bacteremia due to vancomycin-resistant enterococci.
Hayakawa K; Martin ET; Gudur UM; Marchaim D; Dalle D; Alshabani K; Muppavarapu KS; Jaydev F; Bathina P; Sundaragiri PR; Rajuri SD; Khatri J; Pogue JM; Lephart PR; Rybak MJ; Kaye KS
Antimicrob Agents Chemother; 2014 Jul; 58(7):3968-75. PubMed ID: 24798267
[TBL] [Abstract][Full Text] [Related]
15. Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium.
Sakoulas G; Bayer AS; Pogliano J; Tsuji BT; Yang SJ; Mishra NN; Nizet V; Yeaman MR; Moise PA
Antimicrob Agents Chemother; 2012 Feb; 56(2):838-44. PubMed ID: 22123698
[TBL] [Abstract][Full Text] [Related]
16. β-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.
Smith JR; Barber KE; Raut A; Aboutaleb M; Sakoulas G; Rybak MJ
J Antimicrob Chemother; 2015; 70(6):1738-43. PubMed ID: 25645208
[TBL] [Abstract][Full Text] [Related]
17. Comparison of risk factors and outcomes of daptomycin-susceptible and -nonsusceptible vancomycin-resistant Enterococcus faecium infections in liver transplant recipients.
Lewis JD; Barros AJ; Sifri CD
Transpl Infect Dis; 2018 Jun; 20(3):e12856. PubMed ID: 29427322
[TBL] [Abstract][Full Text] [Related]
18. Daptomycin area under the curve to minimum inhibitory concentration ratio by broth microdilution for predicting the outcome of vancomycin-resistant Enterococcus bloodstream infection.
Chuang YC; Lin HY; Wang JT; Yang JL; Lin CY; Huang SH; Chen YC; Chang SC
Biomed Pharmacother; 2022 Nov; 155():113710. PubMed ID: 36156368
[TBL] [Abstract][Full Text] [Related]
19. Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint?
Shukla BS; Shelburne S; Reyes K; Kamboj M; Lewis JD; Rincon SL; Reyes J; Carvajal LP; Panesso D; Sifri CD; Zervos MJ; Pamer EG; Tran TT; Adachi J; Munita JM; Hasbun R; Arias CA
Clin Infect Dis; 2016 Jun; 62(12):1514-1520. PubMed ID: 27045126
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
Hall Snyder A; Werth BJ; Barber KE; Sakoulas G; Rybak MJ
J Antimicrob Chemother; 2014 Aug; 69(8):2148-54. PubMed ID: 24777900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
